Titlebook: Colorectal Cancer; Evidence-based Chemo Maurie Markman,Leonard B. Saltz Book 2007 Humana Press 2007 angiogenesis.cancer.cancer treatment.co

Collision

DIS

萬靈丹

Second-Line Strategies in the Treatment of Patients With Metastatic Colorectal Cancer,is influenced by many factors, such as the nature of the first-line therapy, the potential toxicity of one regimen vs another, and the overall goal of treatment for the patient. In this chapter, we focus our discussion on the therapeutic strategies that can be used in the treatment of colorectal cancer after the failure of first-line therapy.

Discrete

Colorectal Cancer Imaging,of the presence or absence of recurrence in the surgically cured patient, and evaluation of the response or progression of disease in the patient with known metastatic cancer. This chapter explores the role of different imaging modalities in each of these scenarios.

justify

Das Weltmodell von Forrester: WORLD IIPain management is a critical component of the treatment of advanced colorectal cancer. In this chapter, a set of core principles is outlined to assist in the diagnosis and treatment of most causes of pain in the colorectal cancer patient. An algorithmic approach is described to facilitate expeditious and efficacious treatment.

SPER

Pain Management in the Colorectal Cancer Patient,Pain management is a critical component of the treatment of advanced colorectal cancer. In this chapter, a set of core principles is outlined to assist in the diagnosis and treatment of most causes of pain in the colorectal cancer patient. An algorithmic approach is described to facilitate expeditious and efficacious treatment.

Pedagogy

BAN

檔案

大方不好

Philippe Fauquet-Alekhine,Nane Pehuet as a potential antineoplastic strategy began more than 30 yr ago, and numerous angiogenic growth factors have subsequently been identified in large bowel tumors. The most successful antiangiogenic strategy to date has focused on inhibiting vascular endothelial growth factor (VEGF).